Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

65°
- Benton, AR (72018)
  Today
  
  Sunshine and clouds mixed. High 76F. Winds E at 5 to 10 mph..
  
  Tonight
  
  Considerable cloudiness. Low around 50F. Winds ENE at 5 to 10 mph.
  
  Updated: April 7, 2026 @ 10:16 am
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

VYNE Therapeutics Inc. - Common Stock (NQ:VYNE)

0.6114 +0.0077 (+1.28%)

Streaming Delayed Price Updated: 11:30 AM EDT, Apr 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VYNE Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 06, 2023

Via Benzinga

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

VYNE Therapeutics: Q2 Earnings Insights ↗

August 12, 2022

VYNE Therapeutics (NASDAQ:VYNE) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114 ↗

April 07, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 04, 2023

Via Benzinga

VYNE Therapeutics Earnings Perspective: Return On Capital Employed ↗

September 09, 2022

VYNE Therapeutics (NASDAQ:VYNE) brought in sales totaling $126 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 281.5%, resulting in a loss of $8.48 million.

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 10, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 22, 2022

On Thursday, 1076 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 10, 2022

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

VYNE Therapeutics Shares Plummet As Mid-Stage Skin Disease Study Missed Primary Endpoint ↗

August 10, 2022

VYNE Therapeutics Inc. (NASDAQ: VYNE) announced results from the Phase 2a segment of a Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD).

Via Benzinga

VYNE Therapeutics Shares Disappointing Data From Atopic Dermatitis Trial ↗

August 10, 2022

VYNE Therapeutics Inc (NASDAQ: VYNE) has announced results from the Phase 2a segment of Phase 1b/2a trial evaluating FMX114 for mild-to-moderate atopic dermatitis.

Via Benzinga

VYNE Therapeutics Concludes Patient Enrolment in Mid-Stage Study Of Skin Inflammation Candidate ↗

June 17, 2022

VYNE Therapeutics Inc. (NASDAQ: VYNE) has concluded patient enrollment in the Phase 2a study of of its drug candidate FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD).

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 05, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 07, 2022

Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million.

Via Benzinga

VYNE Therapeutics Shares Jump On Encouraging Preclinical Data From VYN201 Program In Rheumatoid Arthritis ↗

March 30, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 18, 2022

Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares increased by 27.8% to $1.77 during Friday's regular session. The current volume of 149.1K shares is 551.4% of...

Via Benzinga

VYNE Therapeutics's Return On Capital Employed Insights ↗

March 18, 2022

According to data from Benzinga Pro, during Q4, VYNE Therapeutics's (NASDAQ:VYNE) reported sales totaled $2.29 million. Despite a 45.64% increase in earnings, the company posted a...

Via Benzinga

Recap: VYNE Therapeutics Q4 Earnings ↗

March 17, 2022

VYNE Therapeutics (NASDAQ:VYNE) reported its Q4 earnings results on Thursday, March 17, 2022 at 08:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder ↗

March 07, 2022

VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disorder of...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 14, 2022

Gainers Avinger (NASDAQ:AVGR) stock moved...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 14, 2022

Gainers ATI Physical Therapy (NYSE:ATIP) stock increased by 22.7% to $3.73 during Friday's regular session. Trading volume for ATI Physical Therapy's stock is 14.3...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 19, 2022

During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by...

Via Benzinga

52 Biggest Movers From Friday ↗

January 18, 2022

Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its...

Via Benzinga

Stocks Swimming in Red Ink as Economic Data Weighs ↗

January 14, 2022

All three major indexes are pacing for their second-straight weekly loss of 2022.

Via Talk Markets

48 Biggest Movers From Yesterday ↗

January 14, 2022

Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 14, 2022

During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

VYNE Therapeutics Inc. - Common Stock (NQ:VYNE)

All News about VYNE Therapeutics Inc. - Common Stock

Sections

Services

Follow Us